Trade Cross Country - CCRN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Cross Country Healthcare Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 20.39 |
Open* | 20.46 |
1-Year Change* | -32.5% |
Day's Range* | 20.17 - 20.7 |
52 wk Range | 15.65-36.90 |
Average Volume (10 days) | 450.67K |
Average Volume (3 months) | 9.12M |
Market Cap | 740.98M |
P/E Ratio | 7.47 |
Shares Outstanding | 35.15M |
Revenue | 2.23B |
EPS | 2.82 |
Dividend (Yield %) | N/A |
Beta | 0.95 |
Next Earnings Date | Feb 20, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 20.39 | 0.49 | 2.46% | 19.90 | 20.77 | 19.90 |
Dec 7, 2023 | 20.81 | 0.85 | 4.26% | 19.96 | 20.82 | 19.75 |
Dec 6, 2023 | 20.23 | -0.18 | -0.88% | 20.41 | 21.41 | 20.11 |
Dec 5, 2023 | 20.94 | -0.86 | -3.94% | 21.80 | 21.80 | 20.60 |
Dec 4, 2023 | 22.00 | 1.55 | 7.58% | 20.45 | 22.05 | 20.45 |
Dec 1, 2023 | 20.63 | 0.66 | 3.30% | 19.97 | 20.90 | 19.97 |
Nov 30, 2023 | 20.22 | 0.12 | 0.60% | 20.10 | 20.23 | 19.49 |
Nov 29, 2023 | 20.33 | -0.36 | -1.74% | 20.69 | 20.91 | 20.19 |
Nov 28, 2023 | 20.67 | 0.52 | 2.58% | 20.15 | 20.85 | 20.10 |
Nov 27, 2023 | 20.67 | 0.53 | 2.63% | 20.14 | 20.99 | 20.14 |
Nov 24, 2023 | 20.69 | -0.02 | -0.10% | 20.71 | 20.98 | 20.65 |
Nov 22, 2023 | 20.82 | -0.23 | -1.09% | 21.05 | 21.26 | 20.50 |
Nov 21, 2023 | 21.00 | 0.30 | 1.45% | 20.70 | 21.66 | 20.70 |
Nov 20, 2023 | 21.31 | 1.63 | 8.28% | 19.68 | 21.40 | 19.67 |
Nov 17, 2023 | 20.42 | -0.05 | -0.24% | 20.47 | 20.53 | 20.08 |
Nov 16, 2023 | 20.31 | 0.21 | 1.04% | 20.10 | 20.38 | 19.59 |
Nov 15, 2023 | 20.29 | 0.95 | 4.91% | 19.34 | 20.40 | 18.75 |
Nov 14, 2023 | 19.62 | 1.58 | 8.76% | 18.04 | 19.70 | 17.91 |
Nov 13, 2023 | 17.89 | -0.06 | -0.33% | 17.95 | 18.09 | 17.66 |
Nov 10, 2023 | 18.25 | 0.13 | 0.72% | 18.12 | 18.34 | 17.67 |
Cross Country Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, February 20, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Cross Country Healthcare Inc Earnings Release Q4 2023 Cross Country Healthcare Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2806.61 | 1676.65 | 836.417 | 822.224 | 816.484 |
Revenue | 2806.61 | 1676.65 | 836.417 | 822.224 | 816.484 |
Cost of Revenue, Total | 2178.92 | 1301.65 | 633.685 | 618.215 | 606.921 |
Gross Profit | 627.686 | 374.999 | 202.732 | 204.009 | 209.563 |
Total Operating Expense | 2537.23 | 1537.35 | 845.577 | 839.913 | 829.443 |
Selling/General/Admin. Expenses, Total | 333.818 | 220.075 | 176.844 | 183.967 | 182.434 |
Depreciation / Amortization | 12.576 | 9.852 | 12.671 | 14.075 | 11.78 |
Unusual Expense (Income) | 11.912 | 5.768 | 22.377 | 23.656 | 28.308 |
Operating Income | 269.38 | 139.304 | -9.16 | -17.689 | -12.959 |
Interest Income (Expense), Net Non-Operating | -14.391 | -6.866 | -2.89 | -6.59 | -5.654 |
Other, Net | 1.336 | 0.77 | -0.28 | 0.068 | 0.418 |
Net Income Before Taxes | 256.325 | 133.208 | -12.33 | -24.211 | -18.195 |
Net Income After Taxes | 188.461 | 132.002 | -12.142 | -55.943 | -15.617 |
Minority Interest | 0 | 0 | -0.82 | -1.77 | -1.234 |
Net Income Before Extra. Items | 188.461 | 132.002 | -12.962 | -57.713 | -16.851 |
Net Income | 188.461 | 132.002 | -12.962 | -57.713 | -16.951 |
Income Available to Common Excl. Extra. Items | 188.461 | 132.002 | -12.962 | -57.713 | -16.851 |
Income Available to Common Incl. Extra. Items | 188.461 | 132.002 | -12.962 | -57.713 | -16.951 |
Diluted Net Income | 188.461 | 132.002 | -12.962 | -57.713 | -16.951 |
Diluted Weighted Average Shares | 37.536 | 37.392 | 36.088 | 35.815 | 35.657 |
Diluted EPS Excluding Extraordinary Items | 5.02081 | 3.53022 | -0.35918 | -1.61142 | -0.47259 |
Diluted Normalized EPS | 5.25413 | 3.68308 | 0.04387 | -1.18209 | 0.04345 |
Total Extraordinary Items | -0.1 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 540.695 | 622.707 | 628.218 | 636.098 | 753.561 |
Revenue | 540.695 | 622.707 | 628.218 | 636.098 | 753.561 |
Cost of Revenue, Total | 417.556 | 483.284 | 489.276 | 492.553 | 583.156 |
Gross Profit | 123.139 | 139.423 | 138.942 | 143.545 | 170.405 |
Total Operating Expense | 507.229 | 578.91 | 578.57 | 583.923 | 676.636 |
Selling/General/Admin. Expenses, Total | 82.008 | 89.186 | 84.118 | 81.317 | 89.201 |
Depreciation / Amortization | 4.432 | 4.904 | 3.162 | 3.214 | 3.481 |
Unusual Expense (Income) | 3.233 | 1.536 | 2.014 | 6.839 | 0.798 |
Operating Income | 33.466 | 43.797 | 49.648 | 52.175 | 76.925 |
Interest Income (Expense), Net Non-Operating | -3.149 | -3.69 | -3.515 | -3.498 | -3.857 |
Other, Net | -0.011 | 0.012 | 0.217 | 0.027 | 1.084 |
Net Income Before Taxes | 30.306 | 40.119 | 46.35 | 48.704 | 74.152 |
Net Income After Taxes | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Minority Interest | 0 | ||||
Net Income Before Extra. Items | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Net Income | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Income Available to Common Excl. Extra. Items | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Income Available to Common Incl. Extra. Items | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Diluted Net Income | 21.345 | 29.436 | 38.791 | 34.793 | 52.894 |
Diluted Weighted Average Shares | 35.524 | 36.56 | 36.921 | 37.492 | 37.757 |
Diluted EPS Excluding Extraordinary Items | 0.60086 | 0.80514 | 1.05065 | 0.92801 | 1.40091 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.66496 | 0.83597 | 1.0963 | 1.05832 | 1.41598 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 675.673 | 508.273 | 183.111 | 183.357 | 194.905 |
Cash and Short Term Investments | 3.604 | 1.036 | 1.6 | 1.032 | 16.019 |
Cash & Equivalents | 3.604 | 1.036 | 1.6 | 1.032 | 16.019 |
Total Receivables, Net | 659.96 | 498.951 | 174.701 | 174.539 | 170.314 |
Accounts Receivable - Trade, Net | 641.611 | 493.91 | 170.003 | 169.528 | 166.128 |
Prepaid Expenses | 11.067 | 7.648 | 5.455 | 6.097 | 6.208 |
Other Current Assets, Total | 1.042 | 0.638 | 1.355 | 1.689 | 2.364 |
Total Assets | 947.839 | 732.809 | 356.973 | 382.374 | 427.003 |
Property/Plant/Equipment, Total - Net | 22.927 | 23.378 | 22.9 | 28.796 | 13.628 |
Property/Plant/Equipment, Total - Gross | 40.609 | 41.107 | 39.913 | 52.072 | 47.104 |
Accumulated Depreciation, Total | -17.682 | -17.729 | -17.013 | -23.276 | -33.476 |
Goodwill, Net | 163.268 | 119.49 | 90.924 | 101.066 | 101.06 |
Intangibles, Net | 44.723 | 48.244 | 40.731 | 50.857 | 75.584 |
Note Receivable - Long Term | 23.058 | 13.998 | 13.115 | 14.273 | 15.726 |
Other Long Term Assets, Total | 18.19 | 19.426 | 6.192 | 4.025 | 26.1 |
Total Current Liabilities | 271.64 | 199.77 | 93.423 | 85.465 | 85.386 |
Payable/Accrued | 109.753 | 49.877 | 45.726 | 43.744 | |
Accrued Expenses | 100.368 | 67.222 | 37.55 | 33.525 | 30.546 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 4.176 | 0 | 5.235 | |
Other Current Liabilities, Total | 12.822 | 18.619 | 5.996 | 6.214 | 5.861 |
Total Liabilities | 490.62 | 435.281 | 202.598 | 219.742 | 209.475 |
Total Long Term Debt | 148.735 | 176.366 | 53.408 | 70.974 | 77.944 |
Long Term Debt | 148.735 | 176.366 | 53.408 | 70.974 | 77.944 |
Deferred Income Tax | 0.247 | 0.19 | 6.592 | 7.523 | 0.095 |
Minority Interest | 0 | 0.534 | 0.868 | 0.67 | |
Other Liabilities, Total | 69.998 | 58.955 | 48.641 | 54.912 | 45.38 |
Total Equity | 457.219 | 297.528 | 154.375 | 162.632 | 217.528 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 292.876 | 321.552 | 310.388 | 305.643 | 303.048 |
Retained Earnings (Accumulated Deficit) | 165.726 | -22.735 | -154.737 | -141.775 | -84.062 |
Other Equity, Total | -1.387 | -1.293 | -1.28 | -1.24 | -1.462 |
Total Liabilities & Shareholders’ Equity | 947.839 | 732.809 | 356.973 | 382.374 | 427.003 |
Total Common Shares Outstanding | 36.3026 | 37.0236 | 36.1773 | 35.8706 | 35.6257 |
Accounts Payable | 158.45 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 445.229 | 505.634 | 648.612 | 675.673 | 660.017 |
Cash and Short Term Investments | 14.301 | 0.673 | 0.291 | 3.604 | 30.32 |
Cash & Equivalents | 14.301 | 0.673 | 0.291 | 3.604 | 30.32 |
Total Receivables, Net | 423.419 | 496.841 | 636.125 | 659.96 | 617.099 |
Accounts Receivable - Trade, Net | 410.373 | 484.885 | 627.076 | 641.611 | 610.897 |
Prepaid Expenses | 4.779 | 6.753 | 10.937 | 11.067 | 3.952 |
Other Current Assets, Total | 2.73 | 1.367 | 1.259 | 1.042 | 8.646 |
Total Assets | 707.739 | 771.13 | 920.541 | 947.839 | 882.512 |
Property/Plant/Equipment, Total - Net | 28.89 | 27.15 | 25.588 | 22.916 | 21.805 |
Property/Plant/Equipment, Total - Gross | 46.067 | 45.287 | 42.035 | 37.344 | 38.402 |
Accumulated Depreciation, Total | -19.805 | -20.443 | -18.953 | -17.682 | -19.846 |
Goodwill, Net | 135.43 | 137.02 | 141.52 | 163.268 | 113.36 |
Intangibles, Net | 57.256 | 60.171 | 63.086 | 44.723 | 46.743 |
Other Long Term Assets, Total | 18.605 | 19.209 | 18.955 | 18.201 | 19.834 |
Total Current Liabilities | 183.578 | 216.027 | 264.908 | 271.64 | 276.79 |
Payable/Accrued | 114.797 | 139.555 | 176.881 | 185.507 | 192.032 |
Accrued Expenses | 60.202 | 59.313 | 73.268 | 76.737 | 75.436 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 8.579 | 17.159 | 14.759 | 9.396 | 9.322 |
Total Liabilities | 238.078 | 300.782 | 468.611 | 490.62 | 459.803 |
Total Long Term Debt | 0 | 31 | 138.443 | 148.735 | 129.755 |
Long Term Debt | 0 | 31 | 138.443 | 148.735 | 129.755 |
Deferred Income Tax | 0.247 | 0.237 | |||
Minority Interest | |||||
Other Liabilities, Total | 54.5 | 53.755 | 65.26 | 69.998 | 53.021 |
Total Equity | 469.661 | 470.348 | 451.93 | 457.219 | 422.709 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 241.732 | 255.216 | 258.144 | 292.876 | 297.143 |
Retained Earnings (Accumulated Deficit) | 229.319 | 216.507 | 195.162 | 165.726 | 126.935 |
Other Equity, Total | -1.394 | -1.379 | -1.38 | -1.387 | -1.373 |
Total Liabilities & Shareholders’ Equity | 707.739 | 771.13 | 920.541 | 947.839 | 882.512 |
Total Common Shares Outstanding | 34.689 | 35.305 | 35.454 | 36.3026 | 36.508 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | |||
Note Receivable - Long Term | 22.329 | 21.946 | 22.78 | 23.058 | 20.753 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 188.461 | 132.002 | -12.142 | -55.943 | -15.717 |
Cash From Operating Activities | 134.05 | -85.618 | 27.204 | 5.542 | 20.997 |
Cash From Operating Activities | 12.576 | 9.852 | 12.671 | 14.075 | 11.78 |
Deferred Taxes | 5.062 | -9.927 | -0.932 | 31.159 | -3.41 |
Non-Cash Items | 34.095 | 19.715 | 30.457 | 30.425 | 35.73 |
Cash Taxes Paid | 82.893 | 3.608 | 0.612 | 0.555 | 1.043 |
Cash Interest Paid | 12.859 | 5.773 | 2.666 | 4.554 | 6.34 |
Changes in Working Capital | -106.144 | -237.26 | -2.85 | -14.174 | -7.386 |
Cash From Investing Activities | -43.874 | -34.046 | -4.615 | -2.94 | -6.678 |
Capital Expenditures | -8.786 | -7.17 | -4.615 | -2.94 | -4.597 |
Other Investing Cash Flow Items, Total | -35.088 | -26.876 | 0 | 0 | -2.081 |
Cash From Financing Activities | -87.599 | 119.094 | -22.01 | -17.599 | -23.767 |
Financing Cash Flow Items | -17.05 | -8.583 | -2.018 | -4.697 | -2.643 |
Issuance (Retirement) of Debt, Net | -35.264 | 127.677 | -19.992 | -12.902 | -16.124 |
Foreign Exchange Effects | -0.009 | 0.006 | -0.011 | 0.01 | -0.07 |
Net Change in Cash | 2.568 | -0.564 | 0.568 | -14.987 | -9.518 |
Issuance (Retirement) of Stock, Net | -35.285 | 0 | 0 | -5 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 29.436 | 188.461 | 149.67 | 114.877 | 61.983 |
Cash From Operating Activities | 46.865 | 134.05 | 129.73 | -10.897 | -29.038 |
Cash From Operating Activities | 4.904 | 12.576 | 9.414 | 6.2 | 2.719 |
Non-Cash Items | 8.514 | 34.095 | 24.232 | 15.285 | 7.534 |
Changes in Working Capital | 4.608 | -106.144 | -56.383 | -150.735 | -103.702 |
Cash From Investing Activities | -3.496 | -43.874 | -6.763 | -3.848 | -2.096 |
Capital Expenditures | -3.678 | -8.786 | -6.763 | -3.848 | -2.096 |
Cash From Financing Activities | -46.681 | -87.599 | -93.674 | 13.987 | 31.308 |
Financing Cash Flow Items | -4.521 | -17.05 | -16.462 | -8.949 | -8.131 |
Issuance (Retirement) of Debt, Net | -10.4 | -35.264 | -52.864 | 22.936 | 39.439 |
Foreign Exchange Effects | -0.001 | -0.009 | -0.009 | 0.001 | -0.002 |
Net Change in Cash | -3.313 | 2.568 | 29.284 | -0.757 | 0.172 |
Deferred Taxes | -0.597 | 5.062 | 2.797 | 3.476 | 2.428 |
Other Investing Cash Flow Items, Total | 0.182 | -35.088 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | -31.76 | -35.285 | -24.348 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 14.2736 | 5110324 | -294741 | 2023-06-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.8146 | 2439813 | -77244 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 5.4052 | 1935204 | -7833 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 5.3886 | 1929252 | 40602 | 2023-06-30 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 5.2992 | 1897238 | -3320 | 2023-06-30 | LOW |
Systematic Financial Management, L.P. | Investment Advisor | 5.2992 | 1897236 | -18115 | 2023-06-30 | LOW |
Simcoe Capital Management, LLC | Hedge Fund | 4.7709 | 1708095 | 0 | 2023-06-30 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.581 | 1282108 | -4705 | 2023-06-30 | LOW |
Aristotle Capital Boston, LLC | Investment Advisor | 2.4791 | 887572 | 11481 | 2023-06-30 | LOW |
Royce Investment Partners | Investment Advisor/Hedge Fund | 2.2126 | 792170 | 136785 | 2023-06-30 | LOW |
Pacer Advisors, Inc. | Investment Advisor | 2.0189 | 722822 | 255052 | 2023-06-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9579 | 700962 | -4889 | 2023-06-30 | LOW |
DWS Investment Management Americas, Inc. | Investment Advisor/Hedge Fund | 1.9555 | 700125 | -5456 | 2023-06-30 | LOW |
Citadel Advisors LLC | Hedge Fund | 1.9106 | 684034 | 664218 | 2023-06-30 | LOW |
Clark (Kevin Cronin) | Individual Investor | 1.7301 | 619421 | 3148 | 2023-06-01 | LOW |
Parametric Portfolio Associates LLC | Investment Advisor | 1.6101 | 576441 | 10790 | 2023-06-30 | LOW |
Federated MDTA LLC | Investment Advisor/Hedge Fund | 1.5836 | 566981 | 223914 | 2023-06-30 | HIGH |
Invesco Capital Management LLC | Investment Advisor | 1.4246 | 510041 | 8583 | 2023-06-30 | LOW |
Intrinsic Edge Capital Management, LLC | Hedge Fund | 1.3814 | 494568 | 444568 | 2023-06-30 | HIGH |
Balyasny Asset Management LP | Hedge Fund | 1.3368 | 478620 | 478620 | 2023-06-30 | HIGH |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cross Country Company profile
About Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. is engaged in providing total talent management services, including workforce solutions, contingent staffing, permanent placement, and consultative services. The Company operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, including temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cross Country Healthcare, Inc. revenues increased 100% to $1.68B. Net income totaled $132M vs. loss of $13M. Revenues reflect Nurse and allied staffing segment increase from $757.9M to $1.61B, Physician Staffing segment increase of 4% to $70.9M. Net Income reflects Nurse and allied staffing segment income increase from $75.3M to $205.7M, Unallocated Corporate Overhead segment loss decrease of 19% to $70.8M.
Equity composition
Common Stock $.0001 Par, 3/11, 100M auth., 31,102,682 issd., Insiders control 3.19%. Initial Public Offering 10/25/01, 7,812,500 shares @ $Ca17 by Merrill Lync & Co. *FY'99 = 5 months due to 7/30/99 inception of operations. *NOTE: 5/03, Name changed from Cross Country, FY'01 financials and Q's are restated for discontinued ops.
Industry: | Employment Services (NEC) |
6551 Park of Commerce Blvd.
BOCA RATON
FLORIDA 33487
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com